To Compare SH T00658ID Over Ortho Tri-Cyclen Lo (US/Canada)
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to compare the oral contraceptive (OC) SH T00658ID over Ortho
Tri-Cyclen Lo administered for 13 cycles to healthy female volunteers between 18 and 50 years
of age who request oral contraceptive protection. Subjects on a levonorgestrel (LNG),
norgestimate (NGM), norethindrone or norethindrone acetate containing oral contraceptive in a
21-day regimen suffering from hormone withdrawal-associated symptoms such as pelvic pain or
headache or both, and willing to continue OC use but to switch to SH T00658ID or Ortho
Tri-Cyclen Lo.